Results 251 to 260 of about 321,312 (283)

Genomic Proximity Mapping for Identification of Chromosomal Aberrations in Multiple Myeloma. [PDF]

Am J Hematol
Kandasamy RK, Hsu JS, Eacker S, Mangelson H, Stephens ZD, Dispenzieri A, Braggio E, Bergsagel PL, Fonseca R, Rajkumar SV, Kumar SK, Baughn LB, Gonsalves WI, Pandey A.   +13 more
europepmc   +1 more source

A High-Fiber, Plant-Based Diet in Myeloma Precursor Disorders: Results from the NUTRIVENTION Clinical Trial and Preclinical Vk*MYC Model. [PDF]

Cancer Discov
Shah UA, Cogrossi LL, Garcés JJ, Policastro A, Castro F, Derkach A, Fei T, DeWolf S, Grioni M, Sisti S, Blaslov J, Adintori PA, Hosszu KK, McAvoy D, Baichoo M, Cross JR, Paredes J, Anuraj A, Raj SS, Pohl C, Zordan P, Zinsmeyer V, Jesus Faustino Ramos RJ, Lorenzoni M, Gipson B, Maclachlan KH, Gradissimo A, Boiocchi L, Aleynick N, Marchigiani C, Pagani S, Salehi E, Koche RP, Chaligne R, Block T, Korde N, Tan CR, Hultcrantz M, Hassoun H, Shah GL, Scordo M, Lahoud OB, Chung DJ, Landau HJ, Peled JU, Clementi N, Chesi M, Bergsagel PL, Mailankody S, Pollak MN, D'Souza A, Landgren O, Chimonas S, Giralt SA, Usmani SZ, Iyengar NM, Lesokhin AM, van den Brink MRM, Bellone M.   +58 more
europepmc   +1 more source

Correction to "Incidence, Clinical Features, and Prognostic Value of New-Onset Renal Impairment in Multiple Myeloma". [PDF]

Cancer Med
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Multiple myeloma

British Journal of Hospital Medicine, 2017
Multiple myeloma is a malignancy of terminally differentiated plasma cells, and patients typically present with bone marrow infiltration of clonal plasma cells and monoclonal protein in the serum and/or urine. The diagnosis of multiple myeloma is made when clear end-organ damage attributable to the plasma cell proliferative disorder or when findings ...
S J, Chavda, K, Yong
openaire   +5 more sources

Multiple Myeloma

Hematology/Oncology Clinics of North America, 2014
Autologous stem cell transplant (ASCT) remains an integral part of the treatment strategy for many myeloma patients. The role of allogeneic stem cell transplant continues to be defined. There is increasing evidence that posttransplant maintenance therapy can significantly improve outcomes.
Sarah A, Holstein, Hong, Liu, Philip L, McCarthy   +2 more
  +7 more sources